This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pharmaceutical companies need to be prepared to answer the call for increased demand and supply into new markets, ensuring the proper resources and logistics framework are in place. Consumers are taking notice of these metrics, and there is demand for action from pharma.
Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets.
New types of stakeholders, little swayed by the strength of a product sales pitch, have been looking to big Pharma to sit more consistently at the patient population management table. care stakeholders, pharma companies are plotting their next move, or, at least they think they are.
The following content was originally published by EVERSANA last June; read on to learn more, and then get EVERSANA’s complete white paper about the benefits of creating reusable infrastructure and resources when it comes to product launches. For decades, the only reusable space vehicle was NASA’s space shuttle.
Entire sets of strategic initiatives, areas of therapeutic focus and primary and specialty care patient protocols have been thrown into disarray; exposing seismic gaps that the pharmaceutical industry can be well-suited to help customers close. Download now. This raises the questions of an organization’s ability to pivot.
Entire sets of strategic initiatives, areas of therapeutic focus and primary and specialty care patient protocols have been thrown into disarray; exposing seismic gaps that the pharmaceutical industry can be well-suited to help customers close. Download now. This raises the questions of an organization’s ability to pivot.
Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets.
Abacus Medicine Pharma Services (AMPS) and Laboratoires CTRS, marketing authorization holder of Orphacol®, are proud to announce a strategic partnership that ensures continuous stock of Orphacol® in Spain. Orphacol® is a pharmaceuticalproduct containing cholic acid, a substance found in the bile, which is used to digest fats.
A vitally important assay used across various stages of drug development and manufacturing, container closure integrity testing (CCIT) involves evaluating packaging systems to determine their ability to protect the stability and sterility of pharmaceuticalproducts. Pharma 4.0. In the fast-approaching era of Pharma 4.0,
Wholesale pharmaceutical companies also offer services such as end formulation contracts, which help pharmaceutical marketing companies and pharmacies locate manufacturing units across regions and coordinate negotiations when required. Discover the top pharmaceutical wholesalers. GDP and GMP advisory.
Packaging plays a vital role in maintaining the quality, safety, user-friendliness and marketability of drugs and other pharmaceuticalproducts. The download contains detailed information on commercial pharmaceutical packaging contractors, and their product and service lines, alongside contact details to aid your hiring decision.
GlobalData’s social media sentiment database reveals that, even over the past year, the trend towards discussion of environmental topics among pharmaceutical influencers has ramped up. To find out how you could benefit, download the whitepaper on this page. Download the whitepaper to find out more.
The list also contains companies providing regulatory services, validations, package design verification testing, quality and microbial testing as well as different products, such as sterile barrier pouches and rigid trays for sterile implants, blister packages, strip packages, vials, ampoules, caps, bottles, desiccants and more.
Freeze drying has found many applications in the production of sensitive and high-value food, drink and pharmaceuticalproducts. There are two main parameters to control, says Daniel Kuchenbecker, Market Manager, Medical & Pharma, Pfeiffer Vacuum. Please check your email to download the Webinar.
Big data analysis can be enormously powerful in providing insights for business strategy throughout the pharma value chain, including in the acceleration of drug discovery and development, optimization of manufacturing processes, management of supply chains and the creation of innovative sales and marketing strategies.
Freeze drying is a crucial technique to prolong the shelf life of pharmaceuticalproducts. Also known as lyophilisation, the technique stabilises and preserves sensitive products such as biologics, and diagnostic kits, in a permanently storable state.
A 2021 GlobalData poll among readers of Pharmaceutical Technology , found that 43% of respondents agreed environmental issues were the most important aspect of ESG that pharma companies needed to address. Download the white paper to learn more. [1] Industry awareness of the issues. The road from ambition to action. 1] [link]. [2]
This publication marks the FDA’s proactive steps to ease the pharmaceutical’s industry transition to these advanced processes, states the announcement. Creating a more resistant supply chain For available products, the guidelines include considerations on the conversion of batch manufacturing practices to continuous manufacturing.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content